Literature DB >> 30014198

[Physical medical aspects of early rehabilitation after proximal femoral fractures].

Katharina Pils1.   

Abstract

Proximal femoral fractures in old age are known as fragility fractures. They are the sequelae of osteoporosis and an expression of a general reduced capacity and an increase in sensory and functional deficits against the background of multimorbidity. They are often caused by reduced compensation strategies. Simultaneously, for many older people they represent a life event. Despite modern osteosynthesis techniques and less stressful anesthesia procedures, the occurrence of a proximal femoral fracture shakes the labile equilibrium of those affected. Proximal femoral fractures are associated with a high risk of mortality. Only some 50% of those affected achieve the pretraumatic functional level again. Therefore, a comprehensive, multiprofessional and interdisciplinary management of these patients is required. The rehabilitation has to start at the time of diagnosis and at the latest after the operation with a comprehensive interdisciplinary management. Pain and complaints during the rehabilitation have to be clarified and targeted, mostly multimodal interventions, must be included.

Entities:  

Keywords:  Discharge management; Geriatric assessment; ICF – International Classification of Functioning, Disability and Health; Pain; Physical therapy

Mesh:

Year:  2018        PMID: 30014198     DOI: 10.1007/s00391-018-1421-9

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.281


  9 in total

Review 1.  [Management of osteoporosis after fragility fractures].

Authors:  M Gosch; U Stumpf; C Kammerlander; W Böcker; H J Heppner; S Wicklein
Journal:  Z Gerontol Geriatr       Date:  2018-01-05       Impact factor: 1.281

2.  Physical Activity After a Hip Fracture: Effect of a Multicomponent Home-Based Rehabilitation Program-A Secondary Analysis of a Randomized Controlled Trial.

Authors:  Katri Turunen; Anu Salpakoski; Johanna Edgren; Timo Törmäkangas; Marja Arkela; Mauri Kallinen; Maija Pesola; Sirpa Hartikainen; Riku Nikander; Sarianna Sipilä
Journal:  Arch Phys Med Rehabil       Date:  2017-01-27       Impact factor: 3.966

Review 3.  Hip fracture.

Authors:  J D Zuckerman
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

4.  Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data.

Authors:  Vera Vandoninck; Michael R van Balken; Enrico Finazzi Agrò; Filomena Petta; Francesco Micali; John P F A Heesakkers; Frans M J Debruyne; Lambertus A L M Kiemeney; Bart L H Bemelmans
Journal:  Neurourol Urodyn       Date:  2003       Impact factor: 2.696

5.  Predictors of falls in elderly people during rehabilitation after hip fracture--who is at risk of a second one?

Authors:  K Pils; F Neumann; W Meisner; W Schano; G Vavrovsky; T J M Van der Cammen
Journal:  Z Gerontol Geriatr       Date:  2003-02       Impact factor: 1.281

6.  Health-related quality of life of patients with hip fracture before and after rehabilitation therapy: discrepancies between physicians' findings and patients' ratings.

Authors:  Costas Papadopoulos; Reinhold Jagsch; Barbara Griesser; Elisabeth Magenheim; Christine Mozelt; Christa Chhatwal; Ilse Kryspin-Exner; Katharina Pils
Journal:  Aging Clin Exp Res       Date:  2007-04       Impact factor: 3.636

7.  Feasibility of progressive strength training shortly after hip fracture surgery.

Authors:  Jan Overgaard; Morten T Kristensen
Journal:  World J Orthop       Date:  2013-10-18

8.  Early coordinated rehabilitation in acute phase after hip fracture - a model for increased patient participation.

Authors:  Gillian Asplin; Gunnel Carlsson; Lena Zidén; Gunilla Kjellby-Wendt
Journal:  BMC Geriatr       Date:  2017-10-17       Impact factor: 3.921

9.  Effectiveness of acute in-hospital physiotherapy with knee-extension strength training in reducing strength deficits in patients with a hip fracture: A randomised controlled trial.

Authors:  Lise Kronborg; Thomas Bandholm; Henrik Palm; Henrik Kehlet; Morten Tange Kristensen
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.